Drug recall · May 25, 2022
Accupril recall
Why: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Accupril (Quinapril HCl Tablets) 10 mg, 90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
- Lots / codes
Lot: DR9639 Exp. MAR 31 2023
- Quantity
- 2079 bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 22, 2022 · Voluntary: Firm initiated
- Classified
- May 16, 2022
- Reported
- May 25, 2022
- Ended
- October 5, 2023
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Quinapril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.